Mario M. Leitao, Jr
@leitaomd
Followers
4K
Following
6K
Media
606
Statuses
8K
I am a gyn oncologist, Fellowship Director, and Director of Minimal Access and Robotic Surgery at Memorial Sloan Kettering Cancer Center. Tweets are my own.
Joined November 2013
👍
Good day, removing bots and scammers from X now. If you’re active and not a bot following me, when you see this post on your feed,say hi 👋🏻 or give thumbs up 👍🏼
0
1
0
Good day, removing bots and scammers from X now. If you’re active and not a bot following me, when you see this post on your feed,say hi 👋🏻 or give thumbs up 👍🏼
62K
7K
111K
#EditorsChoice Not all “aggressive” #EndometrialCancers are equal Key message: they should not be treated as a single entity or used as a staging criterion 🚫 📌 https://t.co/CIH2VyZuJB
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society
0
14
34
🎬 Now Live: Surgical Film Library We’re proud to launch the Surgical Film Library, featuring more than 200 expertly curated surgical films in gynecologic oncology. Developed through IGCS Education360, this on-demand library offers a global collection of techniques, insights,
0
6
14
We’re all smiles at #IGCS2025! 😄 It’s wonderful to see our global gynecologic cancer community reunited in Cape Town — reconnecting, learning, and celebrating together. 💙🌍
0
4
20
Our ARIA II RCT is underway and will give answer to this
🟢 #ICG fluorescence angiography may enhance surgical safety by guiding #bowel perfusion assessment during #OvarianCancer cytoreduction by @stephjeangill @thomasbartlMD @kfischermd @claritasantia @MMontesinos_Alb @braunchristian1 @mattmarchettiMD @yates_elisemann @jhgelissen ✨
1
1
20
This is how it went! Reminder that if you are fully vaccinated and up to date on boosters, you are allowed to celebrate the Fourth of July. Those vaccinated are even permitted to have a backyard barbecue, so long as the number of guests is five or less.
1K
4K
12K
Does not change sOC. HR is not the only thing to look at. And since when is paclitaxel a “standard” for PROC to be compared to?
#myESMO KEYNOTE B96 Improved PFS HR 0.70 in ITT, OS improved in ITT per press release. Only 1-2 priors, only 46% with prior bev, very low prior PARPi. How do we compare to MIRV and nab-pac/relacorilant? And with the tsunami of ADCs - does this change "the" SOC? Not sure
1
0
4
Yea but this isn’t better than MIRV alone
In platinum-resistant #ovariancancer, a new study found mirvetuximab + pembrolizumab helped shrink tumors in ~31% of patients, many heavily pretreated. Side effects were manageable. Read more in @gynoncjnls: https://t.co/YtyWKCQE9y
2
0
7
As I always say — I only see at most “3 groups” as 2 of the curves are overlapping. And POLE not so great as others say??
Validation of comprehensive genomic profiling for prognostic and potential therapeutic molecular classification of #endometrialcancer 🧬 https://t.co/V2mfQQthIz
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert
0
0
12
Join us! October Journal Club This session will explore the lead article in our October issue: “Endometrial carcinosarcoma without myoinvasion” by Giuseppe Cucinella and Mario M. Leitao, Jr., along with its accompanying editorial. When? Thursday, October 16th, from 11:00-11:45
1
4
15
That’s not true. Most are actually cured with no recurrence and RCTs have demonstrated that.
@leitaomd Professor, we should consider abandoning RT after RH in node positive cases. Almost all of them relapse in distant sites
3
0
9
HRs and p-values are but one bit of a story but not the only and most important. Overall assess of curves and absolute differences as important.
1
0
13
Abandoning rad hyst b/c of old RT techniques and data should not be a "standard". Toxicities witth IMRT acceptable and lower after rad hyst and avoids brachy. So, no need to do frozen section on SLNs in cervix ca and then abandon the rad hyst if met https://t.co/RQgMauf8tz
international-journal-of-gynecological-cancer.com
Compared to historical standards, intensity-modulated radiation therapy minimizes radiation dose to critical structures. Here, we characterize acute/chronic complications of intensity-modulated...
1
0
18
Outstanding sessions in robotic surgery @MethodistHosp Leaders in the field: Drs Leitao, Diaz, and Santillan! Exceptional presentations! Bookout Center @MSKCancerCenter @IJGConline @IJGCfellows @IGCSociety @ESGO_society @leitaomd
0
3
22
🎙️ New #IJGCConversations! Dr. @pedroramirezMD discusses #Carcinosarcoma with no #myoinvasion with Drs. Giuseppe Cucinella and Mario M. Leitao Jr. A fascinating discussion on this rare entity—listen now! 🎧🌍 🔗 https://t.co/2oPRttEkGK
@pedroramirezMD @HsuMd @JayrajAarthi
0
8
20